In comparing the post-transplant CKD EVs to the healthy controls, IPA identified the following canonical pathways to be significantly upregulated: granulocyte adhesion diapedesis, T helper cell differentiation, agranulocyte adhesion diapedesis, hepatic fibrosis/stellate cell activation, and IL-17. The gene discussed is IL17A; the disease is Hepatic fibrosis.